Categories
I-CARE Early Covid (187)
I-CARE Flu and RSV (36)
I-PREVENT (153)
I-RECOVER Long Covid (111)
I-RECOVER Post-Vaccine (320)
MATH+ (198)
Tags
ACE2 protein (10)
acute respiratory distress syndrome (14)
Alopecia (7)
Anti-inflammatory (9)
Antidepressants (9)
Ascorbic Acid (12)
autoantibodies (10)
autophagy (24)
Calcifediol (6)
Cancer (9)
Corticosteroids (9)
COVID-19 (270)
COVID-19 Vaccines (8)
Curcumin (8)
Cytokines (12)
Depression (10)
Famotidine (14)
flavonoids (5)
Glucocorticoids (7)
Hydroxychloroquine (12)
Hyperbaric Oxygen Therapy (9)
Inflammation (14)
ivermectin (47)
long COVID (21)
Mast Cells (8)
Melatonin (20)
Methylprednisolone (7)
molnupiravir (5)
N-Acetylcysteine (6)
Non-Invasive Brain Stimulation (8)
Omicron (7)
Oxytocin (8)
Pneumonia (8)
quercetin (15)
SARS-CoV-2 (72)
SARS-CoV-2 mRNA Vaccines (7)
Sepsis (18)
spermidine (11)
Spike Protein (10)
Thiamine (7)
Thrombosis (9)
Tinnitus (12)
Vitamin C (28)
Vitamin D (10)
Zinc (12)
Authors: Liu SL, Li YH, Shi GY, Chen YH, Huang CW, Hong JS PMID: 17084265 DOI: 10.1016/j.jacc.2006.07.036 Abstract Objectives: We investigated whether naloxone could reduce macrophage activation and influence atherosclerotic lesion formation in mice. Background: Macrophages play an important role in the inflammatory process in atherosclerosis. Naloxone could inhibit activation of microglia, the resident macrophage [...]
Categories: I-RECOVER Long Covid
Tags: naloxone
